WEDNESDAY, Dec. 23 (HealthDay News) -- Nearly 5 million doses of a nasal spray version of swine flu vaccine have been recalled because the vaccine loses some potency over time, but not enough to diminish its protective effect, U.S. health officials announced Tuesday.
Influenza Headlines and Flu Vaccination Information
Archive for December 23rd, 2009
More than 11,500 people have died from swine flu worldwide since the pandemic strain was uncovered in April, World Health Organisation data showed Wednesday.
A two-year-old child who had swine flu and underlying medical conditions has died, the Department of Health announces.
A week after 800,000 doses of children's swine flu vaccine were recalled in the United States for losing their potency, a second vaccine maker recalled its A(H1N1) nasal spray for the same reason.
Despite the fact that at least 60 million Americans have been vaccinated against the swine flu, a number of people are still skeptical about the safety of the swine flu vaccine and hesitant to have their children inoculated, researchers said on Tuesday.A poll was taken last week of 1,637 people aged 18 and older, after 100 million vaccine doses became available, reported Reuters.Around 60 ...
Some experts fear travelers will come home with an unwelcome gift, sparking a rise in swine flu cases that many researchers have been warning might show up in early 2010.
A dog in Westchester County is the first in the nation confirmed to be carrying the same strain of swine flu that is infecting humans, experts said yesterday. The 13-year-old mixed-breed male, which is recovering, apparently caught the virus from ...
Drugmaker Medimmune is recalling nearly 5 million doses of swine-flu vaccine because the nasal spray appears to lose strength over time.
A dog in suburban New York is the first in the U.S. confirmed to be carrying the same strain of swine flu that is infecting humans, experts said Tuesday.
Dec. 23 (Bloomberg) -- AstraZeneca Plc recalled 4.7 million doses of its nasal spray version of the swine flu vaccine after routine tests showed a decline in potency, U.S. regulators said.